Recent studies showcase that popular GLP-1 medications, including Ozempic and Wegovy, may provide significant health benefits beyond weight loss and blood sugar management. A sweeping review highlights their effectiveness in reducing risks for up to 42 health conditions, including dementia and heart disease, while also revealing potential side effects. Despite their promise, concerns about misuse and adverse effects, such as nausea and kidney risks, persist. Experts urge careful consideration as the landscape for these medications evolves, with implications for addiction treatment and cognitive health emerging from ongoing research.